Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Kraßnig Stefanie |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Alcaniz, J; Dahlmann, M; Conrad, T; Orthmann, A; Haybaeck, J; Krassnig, S; Wodlej, C; Birkl-Toeglhofer, AM; Kratzsch, T; Kuhn, SA; Joedicke, A; Iduna, F; Hoffmann, J; Walther, W
Molecular analyses of Glioblastoma patient-derived xenograft (PDX) models identify potential targets in treatment resistant tumors
ONCOL RES TREAT. Abstracts 35. Deutscher Krebskongress. 2022; 45(SUPPL 3):47-47.-35. Deutscher Krebskongress. Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung; NOV 13-16, 2022; Berlin, GERMANY.
[Poster]
Web of Science
Leber, S; Krassnig, S; Birkl-Toeglhofer, A; Golob-Schwarzl, N; Wodlej, C; Flunkert, S; Hutter-Paier, B; Kalev, O; Weis, S; Haybaeck, J
Septin2 and 9 Alterations in Human Post mortem Alzheimer’s Disease Brains
Proceedings of The Lancet Summit, 2021. 2021; -The Lancet Summit: Presymptomatic Prevention and Treatment of Neurodegenerative Diseases; Dez 14 - 16, 2021; London (virtual).
[Poster]
Leber, S; Johannes Haybaeck, Stefanie Kraßnig, Anna Töglhofer, Nicole Golob-Schwarzl, Christina Wodlej, Ognian Kalev, Serge Weis, Stephan Sygulla, Marlene Leoni, Stefanie Flunkert, Birgit Hutter-Paier
Septin2 and 9 as contributors to alzheimer's disease
Proceedings of the 4th Joint Annual Meeting of the Swiss and Austrian Societies of Pathology. 2019; -JOINT ANNUAL MEETING SGPATH-ÖGPATH-SSCYT 2019 ; 07 - 09 November 2019 ; Luzern.
[Poster]
Leber SL, Krassnig S, Birkl-Toeglhofer AM, Golob-Shwarzl N, Wodlej C, Llenos IC, Dulay J, Kalev O, Sygulla S, Leoni M, Flunkert S, Hutter-Paier B, Smalla KH, Seidenbecher C, Weis S, Haybaeck J
Septin2 and 9 in Alzeimer´s disease.
Proceedings of the Annual Meeting of the German Society for Neuropathology and Neuroanatomy (DGNN). 2019; -Annual Meeting of the German Society for Neuropathology and Neuroanatomy (DGNN); SEPT 19–21, 2019 ; Magdeburg, GERMANY.
[Oral Communication]
Wodlej, C; Krassnig, S; Kleinegger, F; Birkl-Toeglhofer, AM; Singer, G; Till, H; Benesch, M; Izycka-Swieszewska, E; Czapiewski, P; Haybaeck, J
Eukaryotic initiation factor 4A1 might represent a novel therapeutic target in neuroblastoma
Virchows Archive. 2019; -103. Jahrestagung der Deutschen Gesellschaft für Pathologie (DGP); JUN 13-15, 2019; Frankfurt am Main, GERMANY.
[Oral Communication]
Baehr, A; Krassnig, S; Schinlauer, A; Nass, N; Golob-Schwarzl, N; Wodlej, C; Raicht, A; Speicher, I; von Campe, G; Asslaber, M; Mawrin, C; Benesch, M; Haybaeck, J.
Eukaryotic initiation factors are differentially expressed in pediatric and adult medulloblastoma.
Neurowoche 2018; 91. Kongress der Deutschen Gesellschaft für Neurologie; OCT 30-NOV 3, 2018; Berlin, GERMANY. 2018.
[Poster]
Bracic, S; Kessler, S; Krassnig, S; Gantenbein, N; Mangge, H; Gruber, HJ; Haybaeck, J
Elevated expression of IMP-1 in thyroid cancer
Virchows Archive. 2018; -30th European Conference of Pathology, Pathology: Path to Precision medicine; SEP 10, 2018; Bilbao, SPAIN.
[Poster]
Bracic, S; Krassnig, S; Gantenbein, N; Mangge, H; Gruber, HJ; Haybaeck, J
eIF3p110 expression is elevated in thyroid cancer
VIRCHOWS ARCH. 2018; 473: S103-S103.
[Poster]
Web of Science
Bracic, S; Woltsche, N; Krassnig, S; Seeboeck, R; Zalaudek, I; Haybaeck, J
eIF6 is overexpressed in melanoma of the the skin and might be a novel therapeutic target
Virchows Archive. 2018; -30th European Conference of Pathology, Pathology: Path to Precision medicine; SEP 9, 2018; Bilbao, SPAIN.
[Oral Communication]
Gantenbein, N; Bernhart, E; Anders, I; Golob-Schwarzl, N; Krassnig, S; Wodlej, C; Gogg-Kamerer, M; Lindenmann, J; Fink-Neuboeck, N; Brcic, L; Gollowitsch ,F; Stacher-Priehse ,E; Rolff , J; Hoffmann , J; Silvestri ,A; Regenbrecht ,C; Reinhard, C; Pehserl , AM; Pichler ,M; Sokolova , O; Naumann ,M; Mitterer ,V; Pertschy,B; Bergler, H; Popper, H; Sattler , W; Haybaeck, J
Influence of eukaryotic translation initiation factors in non-small cell lung cancer development and progression
30th European Congress of Pathology, Pathology: Path to Precision medicine; SEP 10, 2018; Bilbao, SPAIN. 2018.
[Poster]
Golob-Schwarzl, N; Wodlej, C; Kleinegger, F; Toeglhofer, AM; Krassnig, S; Thalhammer, M; Aigelsreiter, A; Hayback, J
Eukaryotic Translation Initiation Factors Might Represent a Potential Therapeutic Target for Gallbladder Cancer
ONCOL RES TREAT. 2018; 41: 68-68.-33. Deutscher Krebs Kongress; FEB 21-24, 2018; Berlin, GERMANY.
[Poster]
Web of Science
Golob-Schwarzl N,Krassnig S, Birkl -Toeglhofer A.M, Park Y.N, Gogg-Kamerer M, Puchas P, Vierlinger K, Schröder F, Schicho R, Fickert P, Haybaeck J
New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors
51. Jahrestagung der ÖGGH; Juni 14 - 16, 2018; Salzburg, AUSTRIA. 2018.
[Oral Communication]
Golob-Schwarzl N,Krassnig S, Birkl -Toeglhofer A.M, Park Y.N, Gogg-Kamerer M, Puchas P, Vierlinger K, Schröder F, Schicho R, Fickert P, Haybaeck J
New Liver Biomarker
102. Annual Meeting of the German Society of Pathology. 2018; -102. Annual Meeting of the German Society of Pathology; May, 2018; Berlin.
[Poster]
Herzl, A; Krassnig, S; Wodlej, C; Birkl-Toeglhofer, AM; Golob-Schwarzl, N; Kalev, O; Leoni, M; Sygulla, S; Weis, S; Haybaeck, J;
Inhibiting eIF4F-complex formation might be a novel therapeutic target in
Alzheimer’s disease
International Student Congress, ISC 2018; MAY 31- JUN 2, 2018; Graz, AUSTRIA. 2018.
[Poster]
Kleinegger, F; Wodlej, C; Golob-Schwarzl, N; Birkl-Töglhofer, AM; Krassnig, S; Niedrist, T; Thalhammer, M; Aigelsreiter, A; Rose-John, S; Fickert, P; Rinner, B; Haybäck, J;
Die Rolle des Interleukin-6 Rezeptors im Zuge der Cholangiozellulären Karzinogenese.
Jahrestagung der Deutschen Gesellschaft für Pathologie. 2018; -102. Jahrestagung der DGP; MAI 24-28, 2018; Berlin.
[Poster]
Kleinegger, F; Wodlej, C; Golob-Schwarzl, N; Birkl-Töglhofer, AM; Krassnig, S; Niedrist, T; Thalhammer, M; Aigelsreiter, A; Rose-John, S; Fikert, P; Rinner, B; Haybäck, J;
Classic and Trans Interleukin-6 Signaling Promotes Cholangiocarcinoma
6th International Students Congress. 2018; -6th International Students Congress; MAY 31 - JUNE 2; Graz, AUSTRIA.
[Oral Communication]
Krassnig, S; Baehr, A; Schinlauer, A; Golob-Schwarzl, N; Wodlej, C; Raicht, A; Speicher, I; Poehlmann-Nitsche, A; Asslaber, M; Mawrin, C; Benesch, M; Haybaeck, J
Expression levels of eukaryotic initation factors are altered in paediatric medulloblastoma
Der Pathologe 39: 89-89. 2018; -102. Jahrestagung der Deutschen Gesellschaft für Pathologie; MAY 24-26, 2018; Berlin, GERMANY.
[Oral Communication]
FullText
Leber,SL; Krassnig, S; ;Toeglhofer, AM; Llenos, IC; Dulay, J; Kalev,O; Flunkert, S;Hutter-Paier, B; Weis, S; Haybaeck, J . .
Post mortem study: Septin 2 and 9 as contributors to glial pathology in Alzheimer’s and Parkinson’s disease
31. Jahrestagung der Österreichischen Alzheimer Gesellschaft . 2018; -31. Jahrestagung der Österreichischen Alzheimer Gesellschaft; OCT 19 -20, 2018; Graz.
[Oral Communication]
Orthmann, A; Krassnig, S; Jodicke, A; Linnebacher, M; Silvestri, A; Regenbrecht, C; Fichtner, I; Hoffmann, J
New preclinical models for neuro-oncology: Integrating data from PD3D models and orthotopic xenografts
ONCOL RES TREAT. 2018; 41: 179-179.-Deutscher Krebskongress; FEB 21-24, 2018; Berlin, GERMANY.
[Poster]
Web of Science
Schinagl M; Sele M; Wernitznig S; Pritz E; Bock E; Birkl C; Ropele S; Kraßnig S;
Birkl-Töglhofer A; Sygulla S; Leoni M; HaybäckJ; Gössler W; Leitinger G
Localising Ferritin and Iron in Human Brain Tissue using Immuno-Electron Microscopy
Doctoral Day; NOV 28, 2018; Graz, Austria. 2018.
[Poster]
Sele, M; Wernitznig, S; Birkl, C; Ropele, S; Kraßnig, S; Birkl-Töglhofer, A; Sygulla, S; Leoni, M; Haybäck, J; Gössler, W; Leitinger, G
Electron microscopic techniques to visualize ferritin in the human brain
Abstract book Retain the brain Doctoral Day 2018. 2018; -Doctoral Day 2018; Nov 28, 2018; Graz, Austria.
[Poster]
Sele, M; Wernitznig, S; Birkl, C; Ropele, S; Kraßnig, S; Birkl-Töglhofer, A; Sygulla, S; Leoni, M; Haybäck, J; Gössler, W; Leitinger, G;
Electron microscopic techniques to visualise iron deposits in the human brain
11th FENS Forum of Neroscience; Jul 7-11, 2018; Berlin, Germany. 2018.
[Poster]
Sele, M; Wernitznig, S; Birkl, C; Ropele, S; Kraßnig, S; Birkl-Töglhofer, A; Sygulla, S; Leoni, M; Haybäck, J; Gössler, W; Leitinger, G;
Iron visualisation in the human brain with electron microscopy
19th International Microscopy Congress; SEP 9-14, 2018; Sydney, Ausralia. 2018.
[Oral Communication]
Wodlej, C; Krassnig, S; Golob-Schwarzl, N; Herzl, A; Kleinegger, F; Birkl-Toeglhofer, AM; Gantenbein, N; Speicher, I; Singer, G; Till, H; Izycka-Swieszewska, E; Czapiewski, P; Haybaeck, J;
Die Rolle von eukaryotischen Translations-Initiationsfaktoren als potentielles neues therapeutisches Target beim Neuroblastom
Der Pathologe 39: 94-94. 2018; -102. Jahrestagung der Deutschen Gesellschaft für Pathologie; MAY 24-26,2018; Berlin, GERMANY.
[Oral Communication]
FullText
Wodlej, C; Krassnig, S; Golob-Schwarzl, N; Kleinegger, F; Birkl-Toeglhofer, AM; Herzl, A; Singer, G; Toll, H; Izycka-Swieszewska, E; Czapiewski, P; Haybaeck, J
Eukaryotic Initiation Factor 4A1 as Potential Therapeutic Target in Neuroblastoma
Proceedings of the Doctoral Day. 2018; -Doctoral Day 2018; NOV 28, 2018; Graz, AUSTRIA.
[Poster]
Wodlej, C; Krassnig, S; Golob-Schwarzl, N; Kleinegger, F; Toeglhofer, AM; Sygulla, S; Singer, G; Till, H; Izycka-Swieszewska, E; Czapiewski, P; Hayback, J
The Role of Eukaryotic Translation Initiation Factors as Potential Targets in Neuroblastoma
ONCOL RES TREAT. 2018; 41: 131-131.-33. Deutscher Krebs Kongress; FEB, 21-24, 2018; Berlin, GERMANY.
[Poster]
Web of Science
Golob-Schwarzl, N; Koller, C; Krassnig, S; Gogg-Kamerer, M; Gantenbein, N; Bergler, H; Pertschy, B; Uranitsch, S; Lackner, K; Puntschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, C; Schicho, R; Fickert, P; Lax, S; Haybaeck, J
Translation initiation separates low and high grade colon and rectum carcinoma
EUR J CANCER. 2017; 72: S57-S57.-ECCO European Cancer Congress; JAN 27-30, 2017; Amsterdam, NETHERLANDS.
Doi: 10.1016/S0959-8049(17)30267-8
[Oral Communication]
Web of Science
FullText
FullText_MUG
Golob-Schwarzl, N; Koller, C; Krassnig, S; Gogg-Kammerer, M; Gantenbein, N; Bergler, H; Pertschy, B; Uranitsch, S; Holter, M; El-Heliebi, A; Fuchs, J; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, C; Schicho, R; Fickert, P; Lax, S; Haybaeck, J
Translation initiation separates low and high grade and colon and rectum carcinoma
VIRCHOWS ARCH. 2017; 471: S167-S167.
[Poster]
Web of Science
Golob-Schwarzl N, Krassnig S, Toeglhofer AM, Park YN, Gogg-Kamerer M, Vierlinger K, Schröder F, Rhee H, Schicho R, Fickert P, Haybaeck J
New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors
2017. 2017; -European Congress of Pathology; Sep 2.-6., 2017; Amsterdam.
[Poster]
Golob-Schwarzl, N; Krassnig, S; Park, Y; Gogg-Kamerer, M; Wodlej, C; Vierlinger, K; Schroeder, F; Rhee, H; Schicho, R; Fickert, P; Haybaeck, J
PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors as new biomarkers in liver cancer
VIRCHOWS ARCH. 2017; 471: S164-S164.
[Poster]
Web of Science
Golob-Schwarzl, N; Schweiger, C; Koller, C; Kraßnig, S; Gogg-Kamerer, M; Gantenbein, N; Bergler, H; Pertschy, B; M; Uranitsch, S; Lackner, K; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, CH; Schicho, R; Fickert, P; Lax, S; Haybaeck, J
Eukaryotic initiation factors (eIFs) in colorectal carcinoma
2017. 2017; -European Congress of Pathology; Sep 2.-6., 2017; Amsterdam.
[Poster]
Golob-Schwarzl, N; Schweiger, C; Koller, C; Kraßnig, S; Gogg-Kamerer, M; Gantenbein, N; Bergler, H; Pertschy, B; M; Uranitsch, S; Lackner, K; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, CH; Schicho, R; Fickert, P; Lax, S; Haybaeck, J
Eukaryotic initiation factors (eIFs) in colorectal carcinoma
European Cancer Congress; Jan 27 - 30, 2017; Amsterdam. 2017.
[Poster]
Golob-Schwarzl, N; Schweiger, C; Koller, C; Kraßnig, S; Gogg-Kamerer, M; Gantenbein, N; Bergler, H; Pertschy, B; M; Uranitsch, S; Lackner, K; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, CH; Schicho, R; Fickert, P; Lax, S; Haybaeck, J.
Eukaryotic initiation factors (eIFs), Biomarker in colorectal carcinoma
2017. 2017; -CBmed Biomarker Conference; 13.2.2017; Graz, Austria.
[Poster]
Golob-Schwarzl, N; Schweiger, C; Koller, C; Kraßnig, S; Gogg-Kamerer, M; Gantenbein, N; Bergler, H; Pertschy, B; M; Uranitsch, S; Lackner, K; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H;Regenbrecht,C; Reinhard, CH; Schicho, R; Fickert, P; Lax, S; Haybaeck, J,
Eukaryotic Initiation factors (eIFs) in colorectal carcinoma
19th International AEK Cancer Congress 2017 ; 1 – 3 March 2017 ; Heidelberg, GERMANY. 2017.
[Poster]
Kleinegger, F; Golob-Schwarzl, N; Toeglhofer, AM; Baran, P; Krassnig, S; Niedrist, T; Speicher, I; Rinner, B; Thalhammer, M; Aigelsreiter, A; Lackner, C; Scheller, J; Rose-John, S; Fickert, P; Haybaeck, J
Interleukin-6 Receptor influences cholangiocarcinoma progression
VIRCHOWS ARCH. 2017; 471: S325-S326.-29th European Congress of Pathology; SEP 2-6, 2017; Amsterdam, The Netherlands.
[Poster]
Web of Science
Kleinegger, F; Golob-Schwarzl, N; Toeglhofer, AM; Krassnig, S; Niedrist, T; Speicher, I; Rinner, B; Thalhammer, M; Aigelsreiter, A; Lackner, C; Rose-John, S; Fickert, P; Haybaeck, J;
Die Expression des Interleukin 6 Rezeptors hat Auswirkungen auf das Cholangiozelluläre Karzinom.
101. Jahrestagung der deutschen Gesellschaft für Pathologie . 2017; JUN 22-24; Erlangen, GERMANY.
[Poster]
Kleinegger, F; Wodlej, C; Golob-Schwarzl, N; Birkl-Toeglhofer, AM; Baran, P; Krassnig, S; Niedrist, T; Rinner, B; Thalhammer, M; Aigelsreiter, A; Scheller, J; Rose-John, S; Fickert, P; Haybaeck, J;
The Role of Interleukin-6 Receptor Signaling in Cholangiocarcinoma
Proceedings of the Doctoral Day. 2017; -Proceedings of the Doctoral Day.; DEC 13, 2017; Graz, Austria.
[Poster]
Krassnig, S; Leber,S;Toeglhofer, AM; Llenos, IC; Dulay, J; Kalev,O; Flunkert, S;Hutter-Paier, B; Weis, S; Haybaeck, J
Septins might be additional contributors to glial pathology in Alzheimer’s disease and other neurodegenerative disorders
Proceedings of the 13th International Conference on Alzheimer's and Parkinson's Diseases. 2017; -13th International Conference on Alzheimer's and Parkinson's Diseases; MAR 29-APR 2; Vienna, AUSTRIA.
[Poster]
Krassnig, S; Leber,S;Toeglhofer, AM; Llenos, IC; Dulay, J; Kalev,O; Flunkert, S;Hutter-Paier, B; Weis, S; Haybaeck, J .
Septins might contribute to Alzheimer’s and Parkinson’s disease pathology.
Der Pathologe, Ausgabe 5/2017. 2017; -Herbsttagung der ÖGPath/IAP 2017; SEP 14-16, 2017; Velden, AUSTRIA.
[Poster]
Krassnig, S; Orthmann, A; Toeglhofer, AM; Wohlrab, C; Golob-Schwarzl, N; Wodlej, C; Pennauer, M; Raicht, A; Ali, KM; von Campe, G; Gogg-Kamerer, M; Logi, M; Sygulla, S; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J
Eukaryotic initiation factors might not only represent novel targets for glioma therapies but might also monitor drug effectiveness
VIRCHOWS ARCH. 2017; 471: S46-S46.
[Oral Communication]
Web of Science
Krassnig, S; Toeglhofer, AM; Golob-Schwarzl, N; Wodlej, C; Birkl, C; Kalev, O; Sygulla, S; Leoni, M; Weis, S; Haybaeck, J;
Alterations in the expression levels of eukaryotic initiation factors in Alzheimer’s disease
Der Pathologe Ausgabe 5/2017. 2017; -Herbsttagung der ÖGPath/IAP 2017; SEP 14-16, 2017; Velden, AUSTRIA.
[Poster]
Krassnig, S; Toeglhofer, AM; Golob-Schwarzl, N; Wodlej, C; Kalev, O; Leoni, M; Flunkert, S; Hutter-Paier, B; Weis, S; Haybaeck, J
Eukaryotic initiation factor 4G (eIF4G) is altered in Alzheimer’s disease and might therefore be involved in pathological mechanisms
Proceedings of the 13th International Conference on Alzheimer's and Parkinson's Diseases.. 2017; -13th International Conference on Alzheimer's and Parkinson's Diseases; MAR 29-APR 2; Vienna, AUSTRIA.
[Poster]
Krassnig, S; Wohlrab, C; Orthmann, A;Golob-Schwarzl, N; Toeglhofer, A; Wodlej, C; Pennauer, M; Raicht, A; Mahdy Ali, M; Von Campe, G; Leoni, M; Sygulla, S; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J .
Eukaryotische Initiationsfaktoren stellen ein potenzielles neues therapeutisches Target für die Behandlung von Gliomen dar
101. Jahrestagung der deutschen Gesellschaft für Pathologie ; JUN 22-24; Erlangen, GERMANY. 2017.
[Poster]
Krassnig, S;Orthmann, A; Wohlrab, C; Golob-Schwarzl, N; Toeglhofer, A; Wodlej, C; Pennauer, M; Raicht, A; Mahdy Ali, M; Von Campe, G; Gogg-Kamerer, M; Leoni, M; Sygulla, S; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J
Eukaryotic initiation factors might represent a novel marker to monitor the effectiveness of glioma therapy.
Brain Tumor Meeting 2017; May 18-19, 2017; Berlin, GERMANY. 2017.
[Poster]
Sele, Mariella; Wernitznig, Stefan; Birkl, Christoph; Ropele, Stefan; Kraßnig, Stefanie; Birkl-Töglhofer, Anna Maria; Sygulla, Stephan; Leoni, Marlene; Haybäck, Johannes; Gössler, Walter; Leitinger, Gerd
High Resolution Visualisation of Iron Deposits in the Human Brain.
Abstract book DocDay 2017. 2017; -DocDay 2017; Dez 13, 2017; Graz, Austria.
[Poster]
Toeglhofer AM, Krassnig S, Golob-Schwarzl N, Kalev O, Leoni M, Wodlej C, Weis S, Haybaeck J
Alterations in eukaryotic translation initiation might contribute to Parkinson’s disease pathology
Proceedings of the 13th International Conference on Alzheimer's and Parkinson's Diseases. 2017; -13th International Conference on Alzheimer's and Parkinson's Diseases; MAR 29-APR 2; Vienna, AUSTRIA.
[Poster]
Toeglhofer, AM; Krassnig, S; Golob-Schwarzl, N; Wodlej, C; Birkl, C; Kalev, O; Leoni, M; Flunkert, S; Hutter-Paier, B; Weis, S; Haybaeck, J
Eukaryotic initiation factors are altered in Alzheimer's disease
VIRCHOWS ARCH. 2017; 471: S218-S219.
[Poster]
Web of Science
Toeglhofer, AM; Krassnig, S; Golob-Schwarzl, N; Wodlej, C; Birkl, C; Kalev, O; Leoni, M; Flunkert, S; Hutter-Paier, B; Weis, S; Haybaeck, J;
Eukaryotic initiation factors are altered in Alzheimer’s disease.
Proceedings of the 29th European Congress of Pathology. 2017; -29th European Congress of Pathology; SEP 2-6, 2017; Amsterdam, THE NETHERLANDS.
[Poster]
Wodlej, C; Krassnig, S; Golob-Schwarzl, N; Kleinegger, F; Birkl-Toeglhofer, AM; Sygulla, S; Singer, G; Till, H; Izycka-Swieszewska, E; Czapiewski, P; Haybaeck, J
Eukaryotic Translation Initiation Factors and Their Potential Role as Targets in Neuroblastoma
Proceedings of the Doctoral Day. 2017; -Doctoral Day; 13.12.2017; Graz, AUSTRIA.
[Poster]
Wodlej, C; Krassnig,S; Golob-Schwarzl, N; Sygulla, S; Singer, G; Till, H; Izycka-Swieszewska, E; Czapiewski, P; Haybaeck, J
Eukaryotic Translation Initiation Factors Might Represent Novel Targets in Neuroblastoma
International Student Congress (ISC); MAY 25-27, 2017; Graz, AUSTRIA. 2017.
[Oral Communication]
Golob-Schwarzl, N; Schweiger, C; Koller, C; Krassnig, S; Gogg-Kamerer, Gantenbein, N; Bergler, H; Pertschy, B; M; Uranitsch, S; Lackner, K; Punschart, A, Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, CH; Schicho, R; Fickert, P; Lax, S; Haybaeck, J
Translation Initiation separates low and high grade and colon and rectum carcinoma
Doctoral Day ; 2016; Graz, AUSTRIA. 2016.
[Oral Communication]
Krassnig, S;
Molecular mechanisms in gliomagenesis
ELGGN Meeting Graz 2016; Jun 3-4, 2016; Graz, AUSTRIA. 2016.
[Oral Communication]
Orthmann, A; Hoffmann, A; Ernst, C; Golob-Schwarzl, N; Krassnig, S; Haybaeck, J; Jodicke, A; Kuhn, S; Linnebacher, M; Fichtner, I; Hoffmann, J
Therapeutic response to chemotherapeutic drugs of glioma-PDX and correlation to common mutations identified by panel sequencing
ONCOL RES TREAT. 2016; 39: 160-160.
[Oral Communication]
Web of Science
Toeglhofer, AM; Krassnig, S; Leoni, M; Weis, S; Haybaeck J
Neurotrophic signaling in the liver of neuropsychiatric disorders
Proceedings of the Doctoral Day. 2016; -Doctoral Day; DEC 14, 2016; Graz, AUSTRIA.
[Poster]
Ernst, C; Krassnig, S; Golob-Schwarzl, N; Asslaber, M; Raicht, A; Lederer, E; Spilka, R; Von Campe, G; Orthmann, A; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J
Eukaryotic initiation factors and their contribution to gliomas might be relevant for the development of new therapies
VIRCHOWS ARCH. . 2015; 467: S40-S40.
[Oral Communication]
Web of Science
Krassnig, S; Schweinzer, C, Taub, N; Havas, D; Auer, E; Schreibmayer, W; Hutter-Paier, B; Windisch, M;
IN VITRO AND IN VIVO EFFECTS OF LENTIVIRAL BETA-SYNUCLEIN OVEREXPRESSION ON APP AND TAU PROTEIN.
Neurodegener Dis 2015;15:(suppl 1):I-II. 2015; -International Conference on Alzheimer's & Parkinson's Diseases (AD/PD); MAR 18-22, 2015; Nice, FRANCE.
[Oral Communication]
Krassnig, S; Toeglhofer, A; Flunkert, S; Hutter-Paier, B; Weis, S; Haybaeck, J;
The role of eukaryotic initiation factors (eIFs) in transgenic animal models of Alzheimer’s disease: Tau versus Amyloid.
Doctoral Day; Dez 11, 2015; Graz, AUSTRIA. 2015.
[Oral Communication]
Krassnig, S; Toeglhofer, A; Flunkert, S; Hutter-Paier B; Weis, S; Haybaeck, J;
Alzheimer Krankheit und die Rolle von eukaryotischen Initationsfaktoren (eIFs) in transgenen Mausmodellen-Tau versus Amyloid.
28. Jahrestagung der Österreichischen Alzheimer-Gesellschaft (ÖAG); OKT 23-24, 2015; Linz, AUSTRIA. 2015.
[Oral Communication]
Smolle, E; Krassnig, S; Gantenbein, N; Spindelböck, W; Sipos, B; Hoffmeister, M; Kump, P; Thalhammer, M; Lipp, R; Haybäck, J
Eukaryotic Translation Initiation Factors in Gastroenteropancreatic Neuroendocrine Tumors - A TMA based Study.
Wiener Klinische Wochenschrift. 2015; 127(17-18):724--Jahrestagung der Österreichischen Gesellschaft für Innere Medizin, ÖGIM; SEP 24-26, 2015; Salzburg Congress, Salzburg, AUSTRIA.
[Poster]
Web of Science
Smolle, E; Krassnig, S; Gantenbein, N; Spindelböck, W; Sipos, B; Hoffmeister, M; Kump, P; Thalhammer, M; Lipp, R; Haybäck, J
Eukaryotic translation initiation factors in gastroenteropancreatic neuroendocrine tumours: ATMA based analysis
VIRCHOWS ARCH. 2015; 467: S129-S130.
[Poster]
Web of Science
Smolle, E; Krassnig, S; Gantenbein, N; Spindelböck, W; Sipos, B; Hoffmeister, M; Kump, P; Thalhammer, M; Lipp, R; Haybaeck, J
Eukaryotic Translation Initiation Factors in Gastroenteropancreatic Neuroendocrine Tumors - A TMA based Study.
10. Sailersymposium; JUN 18-19, 2015; Graz, AUSTRIA. 2015.
[Poster]
Smolle, E; Krassnig, S; Gantenbein, N; Spindelboeck, W; Sipos, B; Hoffmeister, M; Kump, P; Thalhammer, M; Lipp, R; Haybaeck, J
Eukaryotic Translation Initiation Factors in Gastroenteropancreatic Neuroendocrine Tumors - A TMA based Study.
Hauptprogramm - 48. Jahrestagung und 26. Fortbildungskurs der ÖGGH. 18.-20. Juni 2015 - Salzburg Kongress.. 2015; -Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; JUN 18-20, 2015; Salzburg Kongress, Salzburg, AUSTRIA.
[Poster]
FullText
Kraßnig, S; Taub, N; Auer, E; Schweinzer, C; Havas, D; Schreibmayer, W; Hutter-Paier, B; Windisch, M
Beta-Synuclein overexpression influences development of brain pathology.
International Student Congress Graz; JUL 4-6, 2013; Graz, AUSTRIA. 2013.
[Poster]
Kraßnig, S; Taub, N; Schweinzer, C; Auer, E; Havas, D; Schreibmayer, W; Hutter-Paier, B; Windisch, M.
Beta-Synuclein overexpression might have adverse effects on development of brain pathology.
Doctoral Day; Dez 9, 2013; Graz, AUSTRIA. 2013.
[Oral Communication]
Kraßnig, S; Taub, N; Auer, E; Havas, D; Schreibmayer, W; Hutter-Paier, B; Windisch, M;
Effects of Beta-Synuclein overexpression on development of brain pathology
Doctoral Day; DEZ 7, 2012; Graz, AUSTRIA. 2012.
[Poster]
Juch,H; Krassnig,S; Gauster, M; Holzapfel-Bauer, M; Dohr, G
Nanotoxicity in the placenta.
Reproductive Toxicology2011; 31(2):260-261.-The First International ENTIS and OTIS Joint Meeting; MAR 26-30, 2011; Jerusalem ISRAEL.
[Oral Communication]